Genetic backgrounds and diagnosis of familial hypercholesterolemia.

Joanna Rogozik, Renata Główczyńska, Marcin Grabowski

Journal: Clinical genetics 2023;105(1):3-12

PMID: 37849044

Abstract

Lipid disorders play a critical role in the intricate development of atherosclerosis and its clinical consequences, such as coronary heart disease and stroke. These disorders are responsible for a significant number of deaths in many adult populations worldwide. Familial hypercholesterolemia (FH) is a genetic disorder that causes extremely high levels of LDL cholesterol. The most common mutations occur in genes responsible for low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), or proprotein convertase subtilisin/kexin type 9 (PCSK9). While genetic testing is a dependable method for diagnosing the disease, it may not detect primary mutations in 20%-40% of FH cases.

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Address: 1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.